Description
Additional file 1.
| Date made available | Jan 1 2020 |
|---|---|
| Publisher | figshare Academic Research System |
Additional file 1 of Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
- Cristina Saura (Contributor)
- Laia Paré (Contributor)
- Aleix Prat (Contributor)
- Violeta Serra (Contributor)
- Eric P. Winer (Contributor)
- Hao Guo (Contributor)
- Nancy U. Lin (Contributor)
- Patricia Villagrasa (Contributor)
- Yisheng Li (Contributor)
- Ian E. Krop (Contributor)
- Pamela Céliz (Contributor)
- Eva Ciruelos (Contributor)
- Jennifer Savoie (Contributor)
- Gordon B. Mills (Contributor)
- Jordi Rodon (Contributor)
- Carlos L. Arteaga (Contributor)
- Ana C. Garrido-Castro (Contributor)
- Joaquin Gavilá (Contributor)
- Romualdo Barroso-Sousa (Contributor)
- Lewis C. Cantley (Contributor)
- David B. Solit (Contributor)
- Begoña Bermejo (Contributor)
- Zhan Xu (Contributor)
Dataset